These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience. McCullough M; Burg M; Lin E; Peng D; Garner W Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629 [TBL] [Abstract][Full Text] [Related]
4. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome). Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073 [TBL] [Abstract][Full Text] [Related]
5. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents. Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222 [TBL] [Abstract][Full Text] [Related]
6. Comparing mortality outcomes of major burns and toxic epidermal necrolysis in a tertiary burns centre. Mahar PD; Wasiak J; Paul E; Watters DA; Kirby J; Gin D; Marsh P; Cleland H Burns; 2014 Dec; 40(8):1743-7. PubMed ID: 24814156 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients treated for toxic epidermal necrolysis. Oplatek A; Brown K; Sen S; Halerz M; Supple K; Gamelli RL J Burn Care Res; 2006; 27(1):26-33. PubMed ID: 16566534 [TBL] [Abstract][Full Text] [Related]
8. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness. Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613 [TBL] [Abstract][Full Text] [Related]
9. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience. Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855 [TBL] [Abstract][Full Text] [Related]
10. The use of porcine xenografts in patients with toxic epidermal necrolysis. Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163 [TBL] [Abstract][Full Text] [Related]
11. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. Palmieri TL; Greenhalgh DG; Saffle JR; Spence RJ; Peck MD; Jeng JC; Mozingo DW; Yowler CJ; Sheridan RL; Ahrenholz DH; Caruso DM; Foster KN; Kagan RJ; Voigt DW; Purdue GF; Hunt JL; Wolf S; Molitor F J Burn Care Rehabil; 2002; 23(2):87-96. PubMed ID: 11882797 [TBL] [Abstract][Full Text] [Related]
12. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131 [TBL] [Abstract][Full Text] [Related]
13. Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. McGee T; Munster A Plast Reconstr Surg; 1998 Sep; 102(4):1018-22. PubMed ID: 9734418 [TBL] [Abstract][Full Text] [Related]
14. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; MaƮtre B Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174 [TBL] [Abstract][Full Text] [Related]
15. Examining triage patterns of inhalation injury and toxic epidermal necrolysis-Stevens Johnson syndrome. Davis JS; Pandya RK; Pizano LR; Namias N; Dearwater S; Schulman CI J Burn Care Res; 2013; 34(5):492-7. PubMed ID: 23966120 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260 [TBL] [Abstract][Full Text] [Related]
17. The use of Biobrane Rogers AD; Blackport E; Cartotto R Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303 [TBL] [Abstract][Full Text] [Related]
18. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Halebian PH; Corder VJ; Madden MR; Finklestein JL; Shires GT Ann Surg; 1986 Nov; 204(5):503-12. PubMed ID: 3767483 [TBL] [Abstract][Full Text] [Related]
19. Microbiological findings and antibacterial therapy in Stevens-Johnson syndrome/toxic epidermal necrolysis patients from a Swedish Burn Center. Tocco-Tussardi I; Huss F; Presman B J Cutan Pathol; 2017 May; 44(5):420-432. PubMed ID: 28075032 [TBL] [Abstract][Full Text] [Related]